NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
CHA University
Boston Scientific Corporation
HKGepitherapeutics
Instituto de Investigación Sanitaria de la Fundación Jiménez DÃaz
Bayer
Kaohsiung Medical University Chung-Ho Memorial Hospital